Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joerg Kraus"'
Autor:
Andrea Harrer, Georg Pilz, Max Einhaeupl, Katrin Oppermann, Wolfgang Hitzl, Peter Wipfler, Johann Sellner, Stefan Golaszewski, Shahrzad Afazel, Elisabeth Haschke-Becher, Eugen Trinka, Joerg Kraus
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31784 (2012)
Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) and interferes with immune cell migration into the central nervous system by blocking the α(4) subunit of very-late activation
Externí odkaz:
https://doaj.org/article/86fd353d2a424d35ad2996a54786c940
Autor:
Johannes Ebmer, Bertram Hölzl, A. Lee Dellon, Anja S. Ruhdorfer, Wolfgang Hitzl, Joerg Kraus, Mihran Azaryan, Susanne Grinzinger
Publikováno v:
Microsurgery. 35:512-517
Microneurolysis of entrapped peripheral nerve has the best chance of success when compression has not created significant axonal loss. The purpose of this study is to learn the best way to identify potential surgical candidates at the earliest time f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125dda392d9c7ecd0c9d3a817b1a0456
https://doi.org/10.1002/micr.22409
https://doi.org/10.1002/micr.22409
Autor:
Katrin Oppermann, Joerg Kraus, Desiree van der Kleij, Johann Sellner, Shahrzad Afazel, Georg Pilz, Eugen Trinka, Elisabeth Haschke-Becher, Peter Wipfler, Theo Rispens, Andrea Harrer
Publikováno v:
Clinical and Experimental Neuroimmunology. 6:172-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7829ee05de65bea745b0caaebffa4a2e
https://doi.org/10.1111/cen3.12194
https://doi.org/10.1111/cen3.12194
Autor:
Elisabeth Haschke-Becher, Joerg Kraus, Wolfgang Hitzl, Peter Wipfler, Peter Strasser, Georg Pilz, Shahrzad Afazel, Katrin Oppermann, Max Einhaeupl, Eugen Trinka, Andrea Harrer
Publikováno v:
Journal of Neuroimmunology. 234:148-154
Natalizumab interferes with immune cell migration into the central nervous system via blocking the alpha-4 subunit of very-late activation antigen-4 (VLA-4). Occurrence of rare but serious progressive multifocal leukoencephalopathy during prolonged n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::985a5e66d1fae1b39c49a432a0dc1ec2
https://doi.org/10.1016/j.jneuroim.2011.03.001
https://doi.org/10.1016/j.jneuroim.2011.03.001
Autor:
Katrin Morgen, Manfred Kaps, Patrick Oschmann, Britta Engelhardt, Roland Bauer, Horst Traupe, Joerg Kraus, Nikolaos Chatzimanolis, Thomas Bregenzer, Benedikte S. Kuehne, Franz Blaes, Erwin Stolz, Jasmin Tofighi
Publikováno v:
Journal of Neurology. 251:464-472
Adhesion molecules (AMs) are believed to regulate the transmigration of blood leukocytes across the blood-brain barrier (BBB), which is an essential step in the pathogenesis of multiple sclerosis (MS). Previous studies have investigated changes of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb58ce5ea3d632352c79f10d56c9a082
https://doi.org/10.1007/s00415-004-0358-7
https://doi.org/10.1007/s00415-004-0358-7
Autor:
Anja S, Ruhdorfer, Mihran, Azaryan, Joerg, Kraus, Susanne, Grinzinger, Wolfgang, Hitzl, Johannes, Ebmer, A Lee, Dellon, Bertram, Hölzl
Publikováno v:
Microsurgery. 35(7)
Microneurolysis of entrapped peripheral nerve has the best chance of success when compression has not created significant axonal loss. The purpose of this study is to learn the best way to identify potential surgical candidates at the earliest time f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcc3f621109400d26b7dd25dcd827f09
https://pubmed.ncbi.nlm.nih.gov/25847628
https://pubmed.ncbi.nlm.nih.gov/25847628
Autor:
C. Laske, N. Chatzimanolis, Joerg Kraus, H. Diehl, J. Tofighi, H Traupe, B. S. Kühne, T. Bregenzer, Manfred Kaps, Patrick Oschmann, R. Bauer
Publikováno v:
European Neurology. 46:210-214
The objective of this study was to investigate the effect of interferon (IFN) beta-1b on the serum levels of soluble tumor necrosis factor receptor 1 (sTNF-R1) and sTNF-R2 in patients with multiple sclerosis (MS) in correlation with clinical and magn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1689654dd293b6092cf6b67fe6a697c
https://doi.org/10.1159/000050807
https://doi.org/10.1159/000050807
Publikováno v:
European Neurology. 57:241-243
Case Report A 40-year-old man presented with agitation, disorientation and optical hallucinations. He had a history of a malignant seminoma that had been treated with orchiectomy 7 years previously. He was admitted to a psychiatric ward of an outside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c2ec5abfad8b434d93d99142b6d318d
https://doi.org/10.1159/000101290
https://doi.org/10.1159/000101290
Autor:
Frank Weber, Jens Kuhle, Uwe K. Zettl, Joerg Kraus, Andrew T. Chan, Michael Guger, Sandra Niendorf, Christoph Kleinschnitz, Michael Linnebank, Andreas Weishaupt, Sven Jarius, Wolfgang Hitzl, Georg Pilz, Sebastian Rauer, Martin Stangel, Florian Lauda, Christian Geis, Heinz Wiendl, Andrea Harrer, Joerg R. Weber, Brigitte Wildemann, Ilya Ayzenberg, Hayrettin Tumani, Manfred Uhr
Publikováno v:
Multiple Sclerosis Journal, 19(9), 1209-1212. SAGE Publications Ltd
Recently, the disappearance of oligoclonal bands (OCBs) from the cerebrospinal fluid (CSF) of a few natalizumab-treated patients with multiple sclerosis (MS) has been reported. This is interesting since CSF-restricted OCB are believed to persist in M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cebc0dbddf0389408138fe9221b97e
https://pubmed.ncbi.nlm.nih.gov/23093485
https://pubmed.ncbi.nlm.nih.gov/23093485
Autor:
Georg Pilz, Andrea Harrer, Joerg Kraus, Eugen Trinka, Stefan Golaszewski, Wolfgang Hitzl, Shahrzad Afazel, Katrin Oppermann, Max Einhaeupl, Elisabeth Haschke-Becher, Peter Wipfler, Johann Sellner
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 2, p e31784 (2012)
PLoS ONE, Vol 7, Iss 2, p e31784 (2012)
Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) and interferes with immune cell migration into the central nervous system by blocking the α(4) subunit of very-late activation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8540922ced0ed9dd2d087f117c0c69
https://pubmed.ncbi.nlm.nih.gov/22363732
https://pubmed.ncbi.nlm.nih.gov/22363732